CD20-Targeted α-Radionuclides Synergize with Immune Checkpoint Inhibition to Treat Murine Lymphoma.
Saved in:
| Title: | CD20-Targeted α-Radionuclides Synergize with Immune Checkpoint Inhibition to Treat Murine Lymphoma. |
|---|---|
| Authors: | O'Steen, Shyril1 (AUTHOR) sosteen@fredhutch.org, Lee, Sang Y.1 (AUTHOR), Comstock, Melissa L.1 (AUTHOR), Kehret, Allie R.1 (AUTHOR), Lin, Yukang1 (AUTHOR), Hamlin, Donald K.2 (AUTHOR), Dexter, Shannon L.1 (AUTHOR), Hippe, Daniel S.3 (AUTHOR), Gooley, Ted A.3 (AUTHOR), Wilbur, D. Scott2 (AUTHOR), Li, Yawen2 (AUTHOR), Walter, Roland B.3,4 (AUTHOR), Till, Brian3,4 (AUTHOR), Orozco, Johnnie J.1,4 (AUTHOR), Green, Damian J.3,4 (AUTHOR) damiangreen@miami.edu |
| Source: | Journal of Nuclear Medicine. May2026, Vol. 67 Issue 5, p693-699. 7p. |
| Database: | Engineering Source |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
